Quest Laboratories (QUESTLAB-SM) Share Price Falls 11.45% to Rs 75
- September 15, 2026
- Posted by: Harsh Piplani
- Category: News
Quest Laboratories Share Price fell to Rs 75 on 15 September 2026, down 11.45% for the day, taking the company’s market capitalisation to Rs 138.8 crore. Quest Laboratories, a Micro Cap stock in the Healthcare sector’s Pharmaceuticals & Drugs industry, opened at Rs 82 and moved lower through the session to an intraday low of Rs 75, with turnover at Rs 0.49 crore.
For investors searching forQuest Laboratories Share Price Today, the verified data confirms a steep single-day decline from the previous close of Rs 84.7. The supplied figures establish the price event clearly, but they do not establish a company-specific catalyst for why the stock is falling today. That is why the stock is trending in market news and stock updates: the move is large enough to draw attention on price action alone.
Beyond the fall, Quest Laboratories Stock News also stands out because the company’s reported valuation multiples and return ratios differ sharply from broader same-industry benchmarks. At the current price, investors tracking Univest may want to monitor whether this decline changes how the market views its low P/E, modest P/B and relatively strong ROE and ROCE within Pharmaceuticals & Drugs.
Quest Laboratories (QUESTLAB-SM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 75 |
| Previous Close | Rs 84.7 |
| Today's Move | -Rs 9.70 (-11.45%) |
| Open | Rs 82 |
| High | Rs 82 |
| Low | Rs 75 |
| Turnover | Rs 0.49 crore |
| Market Capitalisation | Rs 138.8 crore |
| Market Cap Category | Micro Cap |
Quest Laboratories Share Price Today reflects a decisive intraday decline, with the stock falling from a previous close of Rs 84.7 to Rs 75, a drop of Rs 9.7 or 11.45%. The session began at Rs 82, which also marked the day’s high, indicating that the stock failed to build on its opening level and instead weakened as trading progressed. The day low was Rs 75, the same as the current price at the time of the data snapshot, showing that the stock was near the session’s weakest point.
That pattern matters because it points to sustained pressure through the day rather than a brief dip followed by recovery. With turnover at Rs 0.49 crore and market capitalisation at Rs 138.8 crore, Quest Laboratories remains a Micro Cap counter, where price moves can attract outsized attention in the stock market today even without a confirmed company-specific trigger. For readers following Quest Laboratories Share News or a Quest Laboratories Share Price Update on Univest, the key takeaway is straightforward: today’s decline was sharp, broad through the session and notable enough to shift attention toward the stock’s valuation context.
Quest Laboratories (QUESTLAB-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 138.8 crore |
| P/E Ratio | 9.24x |
| P/B Ratio | 1.43x |
| ROE | 24.56% |
| ROCE | 26.87% |
| EPS | Rs 9.16 |
| Book Value Per Share | Rs 59.08 |
| Dividend Yield | 0% |
Quest Laboratories Fundamental Analysis shows a stock that now trades on a P/E ratio of 9.24 and a P/B ratio of 1.43, both important for assessing how the market is pricing its earnings and net worth. At the current price, the stock’s EPS stands at 9.16, which indicates the earnings attributable to each share. Its book value per share is 59.08, giving investors a reference point for the accounting net worth behind each share. The dividend yield is 0, which means the current data does not reflect a cash payout yield at this price.
Profitability ratios add a different layer to Quest Laboratories Stock Analysis. ROE is 24.56% and ROCE is 26.87%, both relatively strong return metrics on the supplied numbers. Together, those figures suggest that the company has been generating solid returns on shareholder equity and capital employed. In simple terms, Quest Laboratories Share Price is falling today even though the supplied fundamental ratios do not look stretched on conventional valuation measures. That contrast is one reason Quest Laboratories Stock News may remain in focus on Univest, especially for investors comparing price behaviour with financial quality rather than treating the day’s move as a standalone signal.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 9.24x |
| Benchmark Median P/E | 32.72x |
| Benchmark Average P/E | 49.15x |
| Benchmark P/E Range | 3.34x to 693.7x |
| Company P/B Ratio | 1.43x |
| Benchmark Median P/B | 3.05x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 24.56% |
| Benchmark Median ROE | 11.69% |
| Benchmark Average ROE | 10.54% |
| Company ROCE | 26.87% |
| Benchmark Median ROCE | 13.24% |
| Benchmark Average ROCE | 13.09% |
| Company Market Capitalisation | Rs 138.8 crore |
| Benchmark Median Market Cap | Rs 704.59 crore |
| Benchmark Average Market Cap | Rs 13,873.11 crore |
Quest Laboratories Share Price also deserves attention because its valuation and profitability sit in a very different position from the broader same-industry benchmark. Within the Healthcare sector and Pharmaceuticals & Drugs industry, the benchmark covers 204 companies, giving useful context for how the stock is priced versus listed peers.
The company’s P/E of 9.24 is far below the same-industry median of 32.72 and average of 49.15 across 169 companies, while still sitting above the minimum of 3.34 and well below the maximum of 693.7. Its P/B of 1.43 is also lower than the industry median of 3.05 and average of 4.37 across 203 companies. On profitability, Quest Laboratories reports ROE of 24.56% versus an industry median of 11.69% and average of 10.54, while ROCE of 26.87% stands above the industry median of 13.24% and average of 13.09.
Size is the main area where it differs from the broader pack. The company’s market capitalisation of Rs 138.8 crore is well below the same-industry median of Rs 704.59 crore and far below the average of Rs 13,873.11 crore. For readers tracking Quest Laboratories Market Cap and sector positioning on Univest, the picture is of a much smaller company trading at lower valuation multiples but posting higher return ratios than many industry benchmarks.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,957.5 | 36.54 | 5.11 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,47,576 | 84.64 | 14.02 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,233.01 | 86.76 | 21.08 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,670.55 | 24.74 | 4.14 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,272.68 | 32.72 | 3.14 | 11.83 | 16 |
Quest Laboratories Share Price looks especially distinct when placed beside larger listed pharmaceutical peers. On valuation, its P/E of 9.24 is below Sun Pharmaceutical Industries at 36.54, Divi’s Laboratories at 84.64, Torrent Pharmaceuticals at 86.76, Zydus Lifesciences at 24.74 and Cipla at 32.72. Its P/B of 1.43 is likewise below Sun Pharma’s 5.11, Divi’s 14.02, Torrent’s 21.08, Zydus’ 4.14 and Cipla’s 3.14.
Profitability is more mixed in that comparison. Quest Laboratories posts ROE of 24.56%, which is above Sun Pharma’s 14.85, Divi’s 16.19, Zydus’ 19.69 and Cipla’s 11.83, though below Torrent Pharmaceuticals’ 26.76. Its ROCE of 26.87 is above Sun Pharma’s 19.11, Divi’s 21.51, Torrent’s 19.27, Zydus’ 21.39 and Cipla’s 16. Market capitalisation, however, remains much smaller at Rs 138.8 crore versus peer market caps ranging from Rs 1,10,272.68 crore to Rs 4,41,957.5 crore in this set. That makes Quest Laboratories Share Price vulnerable to being judged through both small-cap risk and relative-value lenses at the same time.
Why Investors Are Watching Quest Laboratories
- The stock declined 11.45% in a single session, falling from Rs 84.7 to Rs 75.
- Intraday price action stayed weak, with the day’s high at Rs 82 and low at Rs 75.
- The P/E of 9.24 and P/B of 1.43 are below same-industry median and average levels.
- ROE of 24.56% and ROCE of 26.87% are above the supplied industry benchmarks.
- As a Micro Cap pharmaceutical stock, Quest Laboratories Share Price can quickly move into broader market conversation on Univest.
About Quest Laboratories
Quest Laboratories operates in the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry. Based on the supplied classification data, the company is part of a large listed industry universe where valuation and profitability are often compared across established pharmaceutical businesses and smaller emerging players. Its market capitalisation of Rs 138.8 crore places it firmly in the Micro Cap category, which gives it a very different size profile from larger healthcare names even though it is evaluated within the same industry benchmark framework.
Track Quest Laboratories Share Price on Univest
UseUnivest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
Investors using Univest can track Quest Laboratories Share Price Live through a broader stock analysis framework that goes beyond the day’s move. That includes current share price, market capitalisation, valuation ratios such as P/E and P/B, profitability indicators like ROE and ROCE, 52-week levels when available, and sector comparisons. For readers following Quest Laboratories Latest News, Quest Laboratories Company News or Quest Laboratories Shareholding Pattern updates, Univest helps place a single-day decline in wider context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Quest Laboratories Share Price falling today?
Ans. Quest Laboratories Share Price fell 11.45% to Rs 75 from the previous close of Rs 84.7. The supplied data confirms the price event and intraday weakness, but it does not establish a company-specific catalyst for today’s decline.
What is Quest Laboratories Share Price Today?
Ans. Quest Laboratories Share Price Today is Rs 75 at the supplied data timestamp. The stock opened at Rs 82, touched a day high of Rs 82, hit a low of Rs 75 and remained at that lower end.
How much did Quest Laboratories stock fall in today’s session?
Ans. Quest Laboratories stock fell by Rs 9.7 in absolute terms and 11.45% in percentage terms during the session. The move came against a previous close of Rs 84.7 and brought the stock down to Rs 75.
What does today’s price action show for Quest Laboratories?
Ans. Today’s price action shows early weakness and no recovery in the supplied session data. The stock opened at Rs 82, which was also the day’s high, and later declined to Rs 75, the day’s low and current price.
Is Quest Laboratories expensive or cheap versus its industry?
Ans. On the supplied figures, Quest Laboratories appears lower valued than its same-industry benchmark. Its P/E is 9.24 versus the industry median of 32.72, while its P/B is 1.43 versus the median of 3.05.
How strong are Quest Laboratories’ profitability ratios?
Ans. Quest Laboratories reports ROE of 24.56% and ROCE of 26.87%. Both are above the supplied same-industry medians of 11.69% and 13.24 respectively, indicating stronger return ratios than many companies in the benchmark universe.
What are the key fundamental metrics for Quest Laboratories?
Ans. Key supplied metrics include market capitalisation of Rs 138.8 crore, P/E of 9.24, P/B of 1.43, EPS of 9.16, book value of 59.08, ROE of 24.56%, ROCE of 26.87% and dividend yield of 0.
How does Quest Laboratories compare with major pharma peers?
Ans. Quest Laboratories trades at lower P/E and P/B multiples than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla in the supplied peer set. Its ROCE of 26.87 is higher than each of those five peers.
What sector does Quest Laboratories belong to?
Ans. Quest Laboratories belongs to the Healthcare sector and is classified under the Pharmaceuticals & Drugs industry. The supplied same-industry benchmark covers 204 companies, which helps place its valuation, profitability and market-cap position in context.
What should investors monitor after this Quest Laboratories Share Price fall?
Ans. Investors may track whether Quest Laboratories Share Price stabilises after today’s drop and how the market weighs its low valuation against its higher ROE and ROCE. Monitoring broader sector comparison data on Univest can also add context.
